<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">Chloroquine (CQ) and aminoquinoline were extensively used for many years (Sharma 
 <xref ref-type="bibr" rid="CR83">2005</xref>; Navarro et al. 
 <xref ref-type="bibr" rid="CR66">2010</xref>). Ruthenium complexes, widely investigated for many applications in medicine, exhibit anticancer, anti-allergic, and antiparasitic potential, as they correspond to nitric oxide donors for vascular relaxation induction (Donnici et al. 
 <xref ref-type="bibr" rid="CR30">2009</xref>; Levina et al. 
 <xref ref-type="bibr" rid="CR51">2009</xref>; Gambino and Otero 
 <xref ref-type="bibr" rid="CR38">2012</xref>; Lima et al. 
 <xref ref-type="bibr" rid="CR53">2014</xref>; Seuanes et al. 
 <xref ref-type="bibr" rid="CR82">2015</xref>; Correa et al. 
 <xref ref-type="bibr" rid="CR25">2016</xref>; Furrer et al. 
 <xref ref-type="bibr" rid="CR37">2016</xref>; Mazuryk et al. 
 <xref ref-type="bibr" rid="CR59">2016</xref>; Zhang et al. 
 <xref ref-type="bibr" rid="CR98">2016</xref>). The synthesis of ruthenium complexes containing CQ as ligands is an interesting strategy to improve the effectiveness of antimalarial drugs (Sanchez-Delgado et al. 
 <xref ref-type="bibr" rid="CR80">1996</xref>; Biot et al. 
 <xref ref-type="bibr" rid="CR13">2011</xref>; Mart√≠nez et al. 
 <xref ref-type="bibr" rid="CR58">2011</xref>).
</p>
